EE233 LONG-TERM OUTCOMES OF LENACAPAVIR PLUS OPTIMIZED BACKGROUND REGIMEN VERSUS OTHER TREATMENTS FOR MULTI-DRUG RESISTANT HIV VIA A COST-EFFECTIVENESS MODEL
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.481
https://www.valueinhealthjournal.com/article/S1098-3015(22)00682-9/fulltext
Title :
EE233 LONG-TERM OUTCOMES OF LENACAPAVIR PLUS OPTIMIZED BACKGROUND REGIMEN VERSUS OTHER TREATMENTS FOR MULTI-DRUG RESISTANT HIV VIA A COST-EFFECTIVENESS MODEL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00682-9&doi=10.1016/j.jval.2022.04.481
First page :
Section Title :
Open access? :
No
Section Order :
10426